4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

110.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 137.00p
  • 52 Week Low: 66.00p
  • Currency: UK Pounds
  • Shares Issued: 65.49m
  • Volume: 11,654
  • Market Cap: £72.04m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
22.3% below the market average22.3% below the market average22.3% below the market average22.3% below the market average22.3% below the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
61.27% above the market average61.27% above the market average61.27% above the market average61.27% above the market average61.27% above the market average
59.32% above the sector average59.32% above the sector average59.32% above the sector average59.32% above the sector average59.32% above the sector average
Price Chg 3m
92.73% above the market average92.73% above the market average92.73% above the market average92.73% above the market average92.73% above the market average
89.83% above the sector average89.83% above the sector average89.83% above the sector average89.83% above the sector average89.83% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
48.16% above the market average48.16% above the market average48.16% above the market average48.16% above the market average48.16% above the market average
61.40% above the sector average61.40% above the sector average61.40% above the sector average61.40% above the sector average61.40% above the sector average
Momentum 20
59.22% above the market average59.22% above the market average59.22% above the market average59.22% above the market average59.22% above the market average
61.40% above the sector average61.40% above the sector average61.40% above the sector average61.40% above the sector average61.40% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
94.16% below the market average94.16% below the market average94.16% below the market average94.16% below the market average94.16% below the market average
89.83% below the sector average89.83% below the sector average89.83% below the sector average89.83% below the sector average89.83% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
93.24% below the market average93.24% below the market average93.24% below the market average93.24% below the market average93.24% below the market average
79.66% below the sector average79.66% below the sector average79.66% below the sector average79.66% below the sector average79.66% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
11.78% above the market average11.78% above the market average11.78% above the market average11.78% above the market average11.78% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Cash
23.68% above the market average23.68% above the market average23.68% above the market average23.68% above the market average23.68% above the market average
27.59% above the sector average27.59% above the sector average27.59% above the sector average27.59% above the sector average27.59% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
70.03% above the market average70.03% above the market average70.03% above the market average70.03% above the market average70.03% above the market average
44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
20.00% above the market average20.00% above the market average20.00% above the market average20.00% above the market average20.00% above the market average
93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4D Pharma Market Data

Currency UK Pounds
Share Price 110.00p
Change Today 0.50p
% Change 0.46 %
52 Week High 137.00p
52 Week Low 66.00p
Volume 11,654
Shares Issued 65.49m
Market Cap £72.04m

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.75% below the market average14.75% below the market average14.75% below the market average14.75% below the market average14.75% below the market average
35.59% below the sector average35.59% below the sector average35.59% below the sector average35.59% below the sector average35.59% below the sector average
Price Trend
29.7% below the market average29.7% below the market average29.7% below the market average29.7% below the market average29.7% below the market average
5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average
Income Not Available
Growth Not Available

4D Pharma Dividends

No dividends found

Trades for 06-Dec-2019

Time Volume / Share Price
16:16 2,250 @ 110.80p
15:19 402 @ 109.00p
12:59 52,500 @ 110.00p
12:56 25,000 @ 113.00p
12:59 52,500 @ 110.00p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page